- R&D
Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data
Two medications have been shown to drastically alter the prognosis for the fatal skin disease melanoma, according to information gained through a decade of...Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....
- Clinical
AbbVie’s Parkinson’s Drug Meets Phase 3 Trial Goal
AbbVie has disclosed that its late-stage monotherapy prospect substantially decreased the impact of the condition in patients as contrasted with placebo on the same...Experimental Pill by Novo Nordisk Shown to Have Side Effects in Trial
Amycretin, Novo Nordisk's much-anticipated experimental weight-loss drug, was found to be safe in an early-stage trial, with mild to moderate side effects, the company...Biogen and UCB’s lupus drug achieves primary objective in late-stage trial
Biogen and UCB have published a listing of a late-stage clinical trial of dapirolizumab pegol, an experimental drug for treating lupus, a disease in...ITeos drug in combination with GSK’s Jemperli shows positive response in lung cancer treatment
Results from a mid-stage clinical trial conducted by a small biotechnology company iTeos Therapeutics have revealed that when taken in combination with GSK immunotherapy...
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology for Atherosclerosis Treatment
Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to gain access to Genevant’s lipid nanoparticle (LNP) technology delivery system. Repair will specifically...AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai
Immunai, a biotechnology company based in New York, has partnered with AstraZeneca in a multiyear endeavor to try and change the cancer immunotherapy trials...Vicebio Raises $100 Million in Series B Funding to Advance RSV Combination Vaccine Through Phase I
Vicebio, the British biotech, has closed a $100 million Series B funding round as it advances a Phase I study of its bivalent vaccine...
- Technology
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...
- Regulatory
FDA authorizes the first novel schizophrenia therapy in decades
The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizophrenia drug Cobenfy, the first new chemical entity to treat the severe, chronic...Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
- R&D
Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data
Two medications have been shown to drastically alter the prognosis for the fatal skin disease melanoma, according to information gained through a decade of...Onward awarded $1.1M grant from the Christopher & Dana Reeve Foundation to advance BCI research
Onward Medical revealed that it has received a major grant from the Christopher & Dana Reeve Foundation to continue with BCI research. This $1.1M...Germany to Provide 100,000 Mpox Vaccine Doses to Combat Outbreak in Africa
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to help combat the ongoing outbreak in Africa, a government spokesperson...Covid Symptoms Prevented by New Drug Used on Mice, No Risk of Resistance
Research findings from new studies show that organ damage resulting from Covid-19 can be averted by an antioxidant enzyme that shields a cell’s mitochondria....
- Clinical
AbbVie’s Parkinson’s Drug Meets Phase 3 Trial Goal
AbbVie has disclosed that its late-stage monotherapy prospect substantially decreased the impact of the condition in patients as contrasted with placebo on the same...Experimental Pill by Novo Nordisk Shown to Have Side Effects in Trial
Amycretin, Novo Nordisk's much-anticipated experimental weight-loss drug, was found to be safe in an early-stage trial, with mild to moderate side effects, the company...Biogen and UCB’s lupus drug achieves primary objective in late-stage trial
Biogen and UCB have published a listing of a late-stage clinical trial of dapirolizumab pegol, an experimental drug for treating lupus, a disease in...ITeos drug in combination with GSK’s Jemperli shows positive response in lung cancer treatment
Results from a mid-stage clinical trial conducted by a small biotechnology company iTeos Therapeutics have revealed that when taken in combination with GSK immunotherapy...
- Manufacturing
Novo Nordisk Planning Huge $4.1B Plant in NC For Ozempic Production
It seems like GLP-1 giants Novo Nordisk and Eli Lilly are locked in a fierce battle as they work towards scaling production to meet...French Company Orano Med Opens New Radiation Production Facility Near Indianapolis
In a nuclear medicine surge, industry leader Orano Med has selected the U.S. as a production site for further radiopharma development. Orano Med, which...Gerresheimer Increases the Capabilities of Medical Systems in the USA
Gerresheimer, the maker of innovative systems and solutions and a partner to the pharma, biotech, and cosmetics industries, is increasing the production capacity of...Novo Nordisk invests $560 million to increase Chinese medicine production
Novo Nordisk, a prominent player in the pharmaceutical industry, is commemorating three decades of operations in China, coinciding with the potential approval of its...
- Commercial
Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology for Atherosclerosis Treatment
Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to gain access to Genevant’s lipid nanoparticle (LNP) technology delivery system. Repair will specifically...AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai
Immunai, a biotechnology company based in New York, has partnered with AstraZeneca in a multiyear endeavor to try and change the cancer immunotherapy trials...Vicebio Raises $100 Million in Series B Funding to Advance RSV Combination Vaccine Through Phase I
Vicebio, the British biotech, has closed a $100 million Series B funding round as it advances a Phase I study of its bivalent vaccine...
- Technology
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers to carry out clinical trials remotely. This innovation is targeted...Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient
Neuralink, founded by Elon Musk, revealed that it has placed its device in the second human trial subject. The therapeutic application of the technology...AI Firm Formation Bags $372 Series D Funding
In 2024, megarounds have been extremely uncommon. Nonetheless, Formation Bio was able to secure a remarkable series D funding round of $372 million as...Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort
Mohsin Riaz - 0California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part...
- Regulatory
FDA authorizes the first novel schizophrenia therapy in decades
The FDA gave the green light to Bristol Myers Squibb’s much-anticipated schizophrenia drug Cobenfy, the first new chemical entity to treat the severe, chronic...Illumina Gets Favorable Decision Regarding Grail Acquisition
In a decision expected to limit Brussels' merger authority, American gene sequencing firm Illumina prevailed in court against the European Union's inquiry into its...Emergent Bio’s Smallpox Vaccine Gains FDA Approval for Mpox
Emergent BioSolutions' smallpox vaccine has received expanded approval from the U.S. Food and Drug Administration (FDA) for use in individuals at high risk of...Bavarian Nordic Receives Mpox Vaccine Green Light From Singapore
Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by Singapore's Health Sciences Authority (HSA) for the prevention of smallpox and mpox...
- Insights
The Future of Gene Therapies: Three Trends
“Maps don’t show you where you will go in life, they show you where you might go.”—John Green Over...A Patient Centric Approach to Clinical Research is Key for Product Development
Hera Arham - 0Ensuring a patient centric approach during clinical research is vitally important to research sponsors and their partners. A clinical research site that...The FDA and AAV-Based Gene Therapy Safety: What You Should Know
Science fiction author Arthur C. Clarke once commented that “Any sufficiently advanced technology is indistinguishable from magic.” Over the last couple of...Patient Engagement – What History Teaches Us About Pharma’s Future Evolution
The pharmaceutical industry continues to grow by leaps and bounds. Advancements are happening on a weekly basis. But every time we take...
- More
- Podcast
Editor Picks
Servier’s acquisition of Agios’ INDIGO trial bears positive interim results
French drugmaker Servier recently acquired Agios Pharmaceutical’s cancer unit for over $1.5...
Novartis to combine its pharma and oncology operations to save $1 Billion
Novartis has opted for a corporate restructure of operations to aid in...
Ipsen and Genfit Receive Accelerated FDA Nod for Liver Disorder Drug
Initially thought of as a potential game-changer for metabolic-associated steatohepatitis (MASH), Ipsen and Genfit’s...
Must Read
Repair Biotechnologies to Leverage Genevant Sciences’ LNP Technology for Atherosclerosis Treatment
Repair Biotechnologies has joined forces with Swiss company Genevant Sciences to gain access to...
AbbVie’s Parkinson’s Drug Meets Phase 3 Trial Goal
AbbVie has disclosed that its late-stage monotherapy prospect substantially decreased the impact of the...
AstraZeneca Expands AI-Powered Immuno-Oncology Research Partnership with Immunai
Immunai, a biotechnology company based in New York, has partnered with AstraZeneca in a...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com